• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官功能恶化作为脓毒症的一个标志:细胞层面的视角

Deterioration of Organ Function As a Hallmark in Sepsis: The Cellular Perspective.

作者信息

Bauer Michael, Coldewey Sina M, Leitner Margit, Löffler Bettina, Weis Sebastian, Wetzker Reinhard

机构信息

Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.

Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

出版信息

Front Immunol. 2018 Jun 26;9:1460. doi: 10.3389/fimmu.2018.01460. eCollection 2018.

DOI:10.3389/fimmu.2018.01460
PMID:29997622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6028602/
Abstract

Development of organ dysfunction discriminates sepsis from uncomplicated infection. The paradigm shift implicated by the new sepsis-3 definition holds that initial impairment of any organ can pave the way for multiple organ dysfunction and death. Moreover, the role of the systemic inflammatory response, central element in previous sepsis definitions, has been questioned. Most strikingly, a so far largely underestimated defense mechanism of the host, i.e., "disease tolerance," which aims at maintaining host vitality without reducing pathogen load, has gained increasing attention. Here, we summarize evidence that a dysregulation of critical cellular signaling events, also in non-immune cells, might provide a conceptual framework for sepsis-induced dysfunction of parenchymal organs in the absence of significant cell death. We suggest that key signaling mediators, such as phosphoinositide 3-kinase, mechanistic target of rapamycin, and AMP-activated protein kinase, control the balance of damage and repair processes and thus determine the fate of affected organs and ultimately the host. Therapeutic targeting of these multifunctional signaling mediators requires cell-, tissue-, or organ-specific approaches. These novel strategies might allow stopping the domino-like damage to further organ systems and offer alternatives beyond the currently available strictly supportive therapeutic options.

摘要

器官功能障碍的出现可将脓毒症与单纯感染区分开来。脓毒症-3新定义所引发的范式转变认为,任何器官的初始损伤都可能为多器官功能障碍和死亡埋下伏笔。此外,全身炎症反应(先前脓毒症定义中的核心要素)的作用也受到了质疑。最引人注目的是,宿主一种迄今为止被大大低估的防御机制,即旨在在不降低病原体负荷的情况下维持宿主活力的“疾病耐受”,已受到越来越多的关注。在此,我们总结相关证据表明,关键细胞信号事件的失调,即使在非免疫细胞中,也可能为脓毒症诱导的实质器官功能障碍提供一个概念框架,而此时并无明显的细胞死亡。我们认为,关键信号介质,如磷脂酰肌醇3激酶、雷帕霉素靶蛋白和AMP激活的蛋白激酶,控制着损伤与修复过程的平衡,从而决定受影响器官乃至宿主的命运。针对这些多功能信号介质的治疗需要采用细胞、组织或器官特异性方法。这些新策略可能会阻止对其他器官系统的多米诺骨牌式损伤,并提供目前严格支持性治疗选项之外的替代方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142c/6028602/95069699de89/fimmu-09-01460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142c/6028602/5eb937581c1f/fimmu-09-01460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142c/6028602/95069699de89/fimmu-09-01460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142c/6028602/5eb937581c1f/fimmu-09-01460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142c/6028602/95069699de89/fimmu-09-01460-g002.jpg

相似文献

1
Deterioration of Organ Function As a Hallmark in Sepsis: The Cellular Perspective.器官功能恶化作为脓毒症的一个标志:细胞层面的视角
Front Immunol. 2018 Jun 26;9:1460. doi: 10.3389/fimmu.2018.01460. eCollection 2018.
2
The cellular basis of organ failure in sepsis-signaling during damage and repair processes.脓毒症中器官衰竭的细胞基础——损伤与修复过程中的信号传导
Med Klin Intensivmed Notfmed. 2020 May;115(Suppl 1):4-9. doi: 10.1007/s00063-020-00673-4. Epub 2020 Mar 31.
3
Sepsis 2019 - New Trends and Their Implications for Multiple Trauma Patients.2019年脓毒症——新趋势及其对多发伤患者的影响
Z Orthop Unfall. 2020 Feb;158(1):81-89. doi: 10.1055/a-0853-2054. Epub 2019 Sep 9.
4
Sepsis: the need for tolerance not complacency.脓毒症:需要的是宽容而非自满。
Swiss Med Wkly. 2016 Feb 22;146:w14276. doi: 10.4414/smw.2016.14276. eCollection 2016.
5
Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment.磷酸肌醇 3 激酶γ的活性通过改变中性粒细胞的募集而导致脓毒症和器官损伤。
Am J Respir Crit Care Med. 2010 Sep 15;182(6):762-73. doi: 10.1164/rccm.201001-0088OC. Epub 2010 May 27.
6
[Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches].[脓毒症性心肌病:病理生理学及潜在的新治疗方法]
Nihon Yakurigaku Zasshi. 2018;151(3):111-116. doi: 10.1254/fpj.151.111.
7
20 Years On: Is It Time to Redefine the Systemic Inflammatory Response to Cardiothoracic Surgery?20年过去了:是时候重新定义对心胸外科手术的全身炎症反应了吗?
J Extra Corpor Technol. 2015 Mar;47(1):5-9.
8
Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.脓毒症相关性器官功能障碍的病理生理学和分子基础的最新进展:新的治疗意义和挑战。
Pharmacol Ther. 2017 Sep;177:56-66. doi: 10.1016/j.pharmthera.2017.02.040. Epub 2017 Feb 21.
9
Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis.CCR2 在脓毒症中性粒细胞组织浸润和多器官功能障碍中的重要作用。
Am J Respir Crit Care Med. 2011 Jan 15;183(2):234-42. doi: 10.1164/rccm.201003-0416OC. Epub 2010 Aug 23.
10
Liver-lung interactions in critical illness.危重症中的肝肺相互作用。
New Horiz. 1994 Nov;2(4):488-504.

引用本文的文献

1
Exploiting the Zebrafish Model for Sepsis Research: Insights into Pathophysiology and Therapeutic Potentials.利用斑马鱼模型进行脓毒症研究:对发病机制和治疗潜力的深入了解。
Drug Des Devel Ther. 2024 Nov 22;18:5333-5349. doi: 10.2147/DDDT.S500276. eCollection 2024.
2
Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19.细菌败血症和重症 COVID-19 期间炎症反应的区室化
J Intensive Med. 2024 Feb 27;4(3):326-340. doi: 10.1016/j.jointm.2024.01.001. eCollection 2024 Jul.
3
Unraveling the Multifaceted Role of Glutathione in Sepsis: A Comprehensive Review.

本文引用的文献

1
Metabolic Adaptation Establishes Disease Tolerance to Sepsis.代谢适应建立对脓毒症的疾病耐受性。
Cell. 2017 Jun 15;169(7):1263-1275.e14. doi: 10.1016/j.cell.2017.05.031.
2
Hormesis and Defense of Infectious Disease.毒物兴奋效应与传染病防御
Int J Mol Sci. 2017 Jun 15;18(6):1273. doi: 10.3390/ijms18061273.
3
ATP-Induced Inflammasome Activation and Pyroptosis Is Regulated by AMP-Activated Protein Kinase in Macrophages.巨噬细胞中,ATP诱导的炎性小体激活和细胞焦亡受AMP激活的蛋白激酶调控。
解析谷胱甘肽在脓毒症中的多方面作用:一项综述
Cureus. 2024 Mar 25;16(3):e56896. doi: 10.7759/cureus.56896. eCollection 2024 Mar.
4
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial.表柔比星治疗脓毒症和脓毒性休克(EPOS-1):一项随机、安慰剂对照的IIa期剂量递增试验的研究方案
BMJ Open. 2024 Apr 22;14(4):e075158. doi: 10.1136/bmjopen-2023-075158.
5
Controversies Surrounding Albumin Use in Sepsis: Lessons from Cirrhosis.围绕脓毒症中白蛋白使用的争议:肝硬化的教训。
Int J Mol Sci. 2023 Dec 18;24(24):17606. doi: 10.3390/ijms242417606.
6
Roquin-1 resolves sepsis-associated acute liver injury by regulating inflammatory profiles via miRNA cargo in extracellular vesicles.Roquin-1通过调节细胞外囊泡中微小RNA(miRNA)货物的炎症谱来缓解败血症相关的急性肝损伤。
iScience. 2023 Jul 12;26(8):107295. doi: 10.1016/j.isci.2023.107295. eCollection 2023 Aug 18.
7
Mesenchymal stem cell-derived exosome alleviates sepsis- associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis.间质干细胞来源的外泌体通过 microRNA-26a-5p 抑制 MALAT1 缓解脓毒症相关性急性肝损伤:脓毒症的创新免疫药理学干预和治疗方法。
Front Immunol. 2023 Jun 15;14:1157793. doi: 10.3389/fimmu.2023.1157793. eCollection 2023.
8
A pharmacoproteomic landscape of organotypic intervention responses in Gram-negative sepsis.器官型干预反应在革兰氏阴性菌脓毒症中的药物蛋白质组学图谱。
Nat Commun. 2023 Jun 17;14(1):3603. doi: 10.1038/s41467-023-39269-9.
9
Tidy up - The unfolded protein response in sepsis.整理 - 脓毒症中的未折叠蛋白反应。
Front Immunol. 2022 Oct 20;13:980680. doi: 10.3389/fimmu.2022.980680. eCollection 2022.
10
Altered EEG, disrupted hippocampal long-term potentiation and neurobehavioral deficits implicate a delirium-like state in a mouse model of sepsis.改变的脑电图、海马长时程增强受损和神经行为缺陷表明脓毒症小鼠模型中存在一种类似谵妄的状态。
Brain Behav Immun. 2023 Jan;107:165-178. doi: 10.1016/j.bbi.2022.10.003. Epub 2022 Oct 13.
Front Immunol. 2016 Dec 12;7:597. doi: 10.3389/fimmu.2016.00597. eCollection 2016.
4
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9的RNAi治疗抑制剂。
N Engl J Med. 2017 Jan 5;376(1):41-51. doi: 10.1056/NEJMoa1609243. Epub 2016 Nov 13.
5
Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.AMP激活的蛋白激酶(AMPK)对Janus激酶1(JAK1)的磷酸化作用将能量感知与抗炎信号传导联系起来。
Sci Signal. 2016 Nov 8;9(453):ra109. doi: 10.1126/scisignal.aaf8566.
6
History of antimicrobial drug discovery: Major classes and health impact.抗菌药物发现的历史:主要类别和健康影响。
Biochem Pharmacol. 2017 Jun 1;133:4-19. doi: 10.1016/j.bcp.2016.10.001. Epub 2016 Oct 5.
7
Increased lipogenesis in spite of upregulated hepatic 5'AMP-activated protein kinase in human non-alcoholic fatty liver.尽管人类非酒精性脂肪性肝病中肝脏5'-AMP激活蛋白激酶上调,但脂肪生成仍增加。
Hepatol Res. 2017 Aug;47(9):890-901. doi: 10.1111/hepr.12825. Epub 2016 Nov 18.
8
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.血清神经酰胺-1-磷酸水平升高可减轻实验性脓毒症引起的心脏功能障碍。
Sci Rep. 2016 Jun 9;6:27594. doi: 10.1038/srep27594.
9
Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.葡萄球菌小菌落变异株在持续性感染中的临床意义及发病机制
Clin Microbiol Rev. 2016 Apr;29(2):401-27. doi: 10.1128/CMR.00069-15.
10
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.严重脓毒症患者白细胞能量代谢存在广泛缺陷,导致免疫麻痹。
Nat Immunol. 2016 Apr;17(4):406-13. doi: 10.1038/ni.3398. Epub 2016 Mar 7.